Systemic inflammation and tumour-infiltrating T-cell receptor repertoire diversity are predictive of clinical outcome in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements
- Sprache
-
Englisch
- Identifier
-
126900431X
- Thema
-
Krebs ; B-Zell-Lymphom; Immuntherapie
- Beteiligte Personen und Organisationen
-
Olschewski, Vito
Witte, Hanno M.
Bernard, Veronica
Steinestel, Konrad
Peter, Wolfgang
Merz, Hartmut
Rieken, Johannes
Biersack, Harald
von Bubnoff, Nikolas
Feller, Alfred C.
Gebauer, Niklas
- DOI
-
10.18725/OPARU-44786
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
27.10.2022, 11:05 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Olschewski, Vito
- Witte, Hanno M.
- Bernard, Veronica
- Steinestel, Konrad
- Peter, Wolfgang
- Merz, Hartmut
- Rieken, Johannes
- Biersack, Harald
- von Bubnoff, Nikolas
- Feller, Alfred C.
- Gebauer, Niklas
Ähnliche Objekte (12)
CAR T-cell therapy in diffuse large B-cell lymphoma : a practical resource for nurses
Pelger-Huët anomaly and T-cell lymphoma
Panel sequencing of primary cutaneous B-cell lymphoma
Invasive Giant B-Cell Lymphoma Mimicking Fulminant Pulmonary Embolism
Clonal Haematopoiesis in Patients with angioimmunoblastic T-Cell Lymphoma
Targetable alterations in primary extranodal diffuse large B-cell lymphoma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
Quantitative N-glycoproteome, phosphoproteome and ubiquitinome analyses for studying B-cell receptor signaling in B-cell lymphoma
Determining the efficacy of antigen-armed antibody in B-cell lymphoma
Tumor progression in gastric marginal zone B-cell lymphoma of MALT type
COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma
Kruppel-like factor 4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classical Hodgkin lymphoma
CAR T-cell therapy in diffuse large B-cell lymphoma : a practical resource for nurses
Pelger-Huët anomaly and T-cell lymphoma
Panel sequencing of primary cutaneous B-cell lymphoma
Invasive Giant B-Cell Lymphoma Mimicking Fulminant Pulmonary Embolism
Clonal Haematopoiesis in Patients with angioimmunoblastic T-Cell Lymphoma
Targetable alterations in primary extranodal diffuse large B-cell lymphoma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
Quantitative N-glycoproteome, phosphoproteome and ubiquitinome analyses for studying B-cell receptor signaling in B-cell lymphoma
Determining the efficacy of antigen-armed antibody in B-cell lymphoma
Tumor progression in gastric marginal zone B-cell lymphoma of MALT type
COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma
Kruppel-like factor 4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classical Hodgkin lymphoma
CAR T-cell therapy in diffuse large B-cell lymphoma : a practical resource for nurses
Pelger-Huët anomaly and T-cell lymphoma
Panel sequencing of primary cutaneous B-cell lymphoma
Invasive Giant B-Cell Lymphoma Mimicking Fulminant Pulmonary Embolism
Clonal Haematopoiesis in Patients with angioimmunoblastic T-Cell Lymphoma
Targetable alterations in primary extranodal diffuse large B-cell lymphoma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
Quantitative N-glycoproteome, phosphoproteome and ubiquitinome analyses for studying B-cell receptor signaling in B-cell lymphoma
Determining the efficacy of antigen-armed antibody in B-cell lymphoma
Tumor progression in gastric marginal zone B-cell lymphoma of MALT type
COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma